Arecor Therapeutics PLC (GB:AREC) has released an update.
Arecor Therapeutics PLC, a biopharmaceutical company known for enhancing existing therapies to promote healthier lives, has successfully passed all resolutions at its Annual General Meeting. In addition to AGM updates, the company revealed that its Nominated Adviser and Joint Broker has undergone a name change to Panmure Liberum Limited after a corporate merger. Arecor continues to focus on developing its proprietary portfolio and partnering with major industry players through its Arestat™ technology platform.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.
